Given that PCLP1 has been previously reported to be expressed on malignant B cells from B-cell acute lymphoblastic leukemia (B-ALL) patients, we included the expression of this protein in 3 ALL patients as a positive procedure control. Here, PODXL is linked to B-cell acute lymphoblastic leukemia.